State KY
Clinical Trials in Kentucky
Kentucky is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kentucky and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 140 actively recruiting studies with Kentucky sites out of 140 registered in total. The busiest research areas in Kentucky are Non-Small Cell Lung Cancer, Colorectal Cancer, Ulcerative Colitis. Leading sponsors running trials in the state include University of Louisville, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Kentucky trials break down as Phase 1 (20), Phase 2 (36), Phase 3 (42), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kentucky
Frequently Asked Questions — Clinical Trials in Kentucky
How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 140 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 140. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Non-Small Cell Lung Cancer, Colorectal Cancer, Ulcerative Colitis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kentucky
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
NCT07766005 Phase 2
Recruiting
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States, Canada
Sponsor
Spyre Therapeutics, Inc.
NCT05552222 Phase 3
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR)...
Condition
Multiple Myeloma
Enrollment
1,590 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT02744677 N/A
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients...
Condition
Complex Congenital Heart Defect
Enrollment
108 pts
Location
United States
Sponsor
Edwards Lifesciences
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
NCT04866472 N/A
Recruiting
Comparison Using a VLS Using GlideRite Stylet Versus TCI Articulating Introducer...
Condition
Predicted Difficult Airway
Enrollment
160 pts
Location
United States
Sponsor
University of Louisville
NCT04554212 N/A
Recruiting
Blood Flow Restriction Training After Patellar INStability
Condition
Patellar Dislocation
Enrollment
78 pts
Location
United States
Sponsor
Caitlin Conley
NCT07770100 Phase 2
Recruiting
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation T...
Condition
Head and Neck Cancer
Enrollment
35 pts
Location
United States
Sponsor
Mark Bernard
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07533331 N/A
Recruiting
Testing Conversational Agents as a Digital Companion
Condition
Autism
Enrollment
38 pts
Location
United States
Sponsor
Friendi.fi Corporation
NCT05446272 N/A
Recruiting
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Condition
Extubation Failure
Enrollment
478 pts
Location
United States, Canada
Sponsor
University of Pennsylvania
NCT05218083 N/A
Recruiting
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program W...
Condition
COVID-19
Enrollment
120 pts
Location
United States
Sponsor
Duke University
NCT07224425 Phase 1
Recruiting
A Study of BI 3810944 in Patients With Advanced Cancer
Condition
Solid Tumours
Enrollment
69 pts
Location
United States, Belgium, Netherlands
Sponsor
Boehringer Ingelheim
NCT07337590 N/A
Recruiting
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Condition
Colorectal Cancer
Enrollment
80 pts
Location
United States
Sponsor
Exero Medical Ltd.
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06880835 N/A
Recruiting
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypogl...
Condition
Diabetes Mellitus, Type 1
Enrollment
30 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
NCT05421741 Phase 4
Recruiting
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Condition
Osteomyelitis Tibia
Enrollment
242 pts
Location
United States
Sponsor
Wake Forest University Health
NCT05882058 Phase 2
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With...
Condition
Small Cell Lung Carcinoma
Enrollment
204 pts
Location
United States, Belgium, Bulgaria
Sponsor
Boehringer Ingelheim
NCT07250958 N/A
Recruiting
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
Condition
Aneurysmal Subarachnoid Hemorrhage
Enrollment
30 pts
Location
United States
Sponsor
University of Louisville
NCT07863635 Phase 4
Recruiting
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-co...
Condition
SARS-CoV-2
Enrollment
600 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
NCT05493215 Phase 2
Recruiting
Imatinib TDM in GIST
Condition
Gastrointestinal Stromal Tumors
Enrollment
28 pts
Location
United States
Sponsor
Reema A. Patel
NCT06998524 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Typ...
Condition
Von Willebrand Disease, Type 3
Enrollment
75 pts
Location
United States, Belgium, Canada
Sponsor
Hoffmann-La Roche
Page 1 of 6 — 140 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology